The global life sciences market is exploding. Valued at $108 billion USD in 2026, and projected to reach $245 billion by 2033, biotech, pharma R&D and healthcare expansion are driving this critical growth. Yet, small and mid-size enterprises (SMEs) like CROs, early stage biotechs and digital health firms often lack the structured marketing needed to capture this share - despite being the drivers of innovation in the sector. The Scale-Up Growth Challenge in a Booming Market Li

B2B client meetings usually start the same: "We want to grow: we need to increase sales and bring in new clients". And usually, these...

Q4 is not just the final stretch. It’s your last call for growth . While many companies rush to push out campaigns or overspend to meet...

As a marketer, have you ever been asked to justify marketing spend? Have you ever been asked by a potential customer how you plan on...